Valued at a market cap of $12.7 billion, Solventum Corporation (SOLV) is a healthcare company that develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs. The Maplewood, Minnesota-based company's offerings span medical supplies, dental care, health information systems, and purification technologies. Companies worth $10 billion or more are typically classified as “large-cap stocks,” and SOLV fits the label perfectly, with its market cap exceeding ...

公司概况 - Becton Dickinson and Company (BDX) 是医疗用品领域领先供应商 业务覆盖生命科学、输液、诊断等多个市场 [1] - 公司股息收益率达2.5% 为十年来最高水平 且当前估值显著低估 [1] - 股息安全性表现优异 具备可持续增长特性 [1] 投资价值 - 公司符合大型股价值投资标准 兼具股息持续增长潜力与资本增值空间 [1] - 除医疗板块外 科技领域及中小市值成长股也是重点关注方向 [1] 作者背景 - 分析观点来自有25年经验的个人投资者 专注股息增长型长期投资策略 [1] - 在28,000多名财经博主中位列前2% (2023年12月Tip Ranks数据) [1]